Armando Orlandi, Medical Director at the Agostino Gemelli University Hospital Foundation IRCCS, shared a post on LinkedIn:
“Gemelli Polyclinic Foundation at ESMO 2025: Advancing Together Through Scientific Excellence
It is with great pride that our oncology delegation from Fondazione Policlinico Universitario Agostino Gemelli IRCCS, under the distinguished leadership of Prof. Giampaolo Tortora, participates in ESMO25 Barcelona.
This congress represents more than a scientific meeting – it embodies our collective commitment to transforming cancer care through:
Knowledge Exchange in Breast Cancer: Engaging with breakthrough data from pivotal trials including DESTINY-Breast09, HORIZON-Breast01, and TROPION-Breast02, which are reshaping treatment paradigms in HER2+ and triple-negative breast cancer. Update data in adjuvant setting in luminal with OS positive results of monarchE and iDFS and DDFS at 5y of NATALEE.
Global Collaboration: Building bridges with international colleagues to foster multicenter research initiatives and clinical trial participation
Scientific Dissemination: Sharing our institutional experience and contributing to the global oncology dialogue through presentations and discussions
Innovation Transfer: Bringing cutting-edge therapeutic strategies back to our patients at Gemelli, ensuring rapid translation from bench to bedside
The future of oncology lies not in isolated excellence, but in our ability to grow together as a global scientific community. Each connection made, each insight shared, strengthens our collective mission against cancer.”
Follow the latest ESMO 2025 news on OncoDaily.